• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无法切除的肝母细胞瘤的手术策略。

Surgical strategies for unresectable hepatoblastomas.

机构信息

Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.

出版信息

J Pediatr Surg. 2012 Dec;47(12):2194-8. doi: 10.1016/j.jpedsurg.2012.09.006.

DOI:10.1016/j.jpedsurg.2012.09.006
PMID:23217875
Abstract

BACKGROUND

The aim of this study was to assess the surgical strategies for unresectable hepatoblastomas at the initial diagnosis based on the experience of two institutions.

METHODS

The PRETEXT (Pretreatment evaluation of tumor extent) and POST-TEXT (Post treatment extent of disease) staging, surgical treatments, and clinical outcomes were retrospectively analyzed for 12 cases with PRETEXT III or IV and M(-) of 29 hepatoblastomas treated based on the JPLT-2 (The Japanese Study Group for Pediatric Liver Tumor-2) protocol at two institutions between 1998 and 2011.

RESULTS

Two of the 9 cases with PRETEXT III status were downstaged to POST-TEXT II. One of the 3 cases with PRETEXT IV showed downstaging to POST-TEXT III. Four of the 7 cases with P2 or V3 (indicated for liver transplantation) in the PRETEXT staging system showed P2 or V3 in POST-TEXT staging after 2 cycles of CITA (JPLT-2 standard regimen), and one case showed P2 or V3 in POST-TEXT staging at the initial operation and underwent primary liver transplantation. The initial surgical treatments were 1 lobectomy, 2 segmentectomies, 6 trisegmentectomies, 2 mesohepatectomies, and 1 primary liver transplantation. Both patients who underwent mesohepatectomies had bile leakage, and 1 of 5 trisegmentectomies had an acute obstruction of the right hepatic vein. Two patients underwent rescue living donor liver transplantation. Both of these patients showed P2 or V3 positive findings in POST-TEXT staging after 2 cycles of CITA.

CONCLUSIONS

POST-TEXT staging and P and V factors should be evaluated after 2 cycles of CITA for unresectable hepatoblastomas detected at the initial diagnosis. The patients should be referred to the transplantation center if the POST-TEXT IV, P2, or V3 is positive at that time. Liver resection by trisegmentectomy is recommended in view of the incidence of surgical complications. Careful treatment, such as back-up transplantation, should thus be considered for liver resection in the cases with POST-TEXT IV, P2, or V3 status after initial 2 cycles of CITA.

摘要

背景

本研究旨在根据两家机构的经验,评估初始诊断为不可切除肝母细胞瘤的手术策略。

方法

回顾性分析了 1998 年至 2011 年两家机构根据 JPLT-2(日本小儿肝肿瘤研究组-2)方案,对 29 例 M(-)肝母细胞瘤中 PRETEXT III 或 IV 期和 PRETEXT III 或 IV 期的 12 例患儿的 PRETEXT(肿瘤术前评估)和 POST-TEXT(术后疾病程度)分期、手术治疗和临床结果。

结果

9 例 PRETEXT III 期中有 2 例降期为 POST-TEXT II 期。3 例 PRETEXT IV 期中有 1 例降期为 POST-TEXT III 期。PRETEXT 分期系统中 7 例 P2 或 V3(提示肝移植)中有 4 例在 CITA(JPLT-2 标准方案)2 个周期后 P2 或 V3,1 例在初始手术时 P2 或 V3,并进行了原发性肝移植。初始手术治疗为 1 例肝叶切除术、2 例节段切除术、6 例三叶切除术、2 例中肝切除术和 1 例原发性肝移植。行中肝切除术的 2 例患者均有胆漏,5 例三叶切除术中有 1 例右肝静脉急性梗阻。2 例患者行挽救性活体肝移植。这 2 例患者在 CITA 2 个周期后 POST-TEXT 分期均为 P2 或 V3 阳性。

结论

对于初始诊断为不可切除的肝母细胞瘤,在 CITA 2 个周期后应评估 POST-TEXT 分期和 P、V 因子。如果此时 POST-TEXT IV、P2 或 V3 阳性,应将患者转至移植中心。鉴于手术并发症的发生率,建议行三叶切除术进行肝切除术。对于初始 CITA 2 个周期后出现 POST-TEXT IV、P2 或 V3 状态的病例,应考虑备用移植等精心治疗。

相似文献

1
Surgical strategies for unresectable hepatoblastomas.无法切除的肝母细胞瘤的手术策略。
J Pediatr Surg. 2012 Dec;47(12):2194-8. doi: 10.1016/j.jpedsurg.2012.09.006.
2
[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].[高风险和标准风险肝母细胞瘤的差异化治疗方案——德国肝脏肿瘤研究HB99的中期报告]
Klin Padiatr. 2003 May-Jun;215(3):159-65. doi: 10.1055/s-2003-39375.
3
Outcome of central hepatectomy for hepatoblastomas.肝母细胞瘤中央切除术的结果。
J Pediatr Surg. 2010 Mar;45(3):555-63. doi: 10.1016/j.jpedsurg.2009.09.025.
4
Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.新辅助化疗对 III 期和 IV 期肝母细胞瘤可切除性的影响。
Br J Surg. 2015 Jan;102(1):108-13. doi: 10.1002/bjs.9681. Epub 2014 Oct 28.
5
Survival after liver transplantation for hepatoblastoma: a 2-center experience.肝母细胞瘤肝移植后的生存情况:一项双中心经验。
J Pediatr Surg. 2008 Nov;43(11):1973-81. doi: 10.1016/j.jpedsurg.2008.05.031.
6
Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.改变儿童肝母细胞瘤的治疗方法和结局:对过去 20 年单中心经验的分析。
J Pediatr Surg. 2012 Jul;47(7):1331-9. doi: 10.1016/j.jpedsurg.2011.11.073.
7
Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.化疗后不可切除肝母细胞瘤的初始肝移植。
Pediatr Blood Cancer. 2011 Dec 15;57(7):1270-5. doi: 10.1002/pbc.23301. Epub 2011 Sep 9.
8
Successful liver transplant for unresectable hepatoblastoma.不可切除性肝母细胞瘤的成功肝移植术。
J Pediatr Surg. 2007 Jan;42(1):184-7. doi: 10.1016/j.jpedsurg.2006.09.017.
9
Avoiding liver transplantation in post-treatment extent of disease III and IV hepatoblastoma.避免在治疗后疾病范围为III期和IV期的肝母细胞瘤患者中进行肝移植。
Pediatr Int. 2018 Sep;60(9):862-868. doi: 10.1111/ped.13634. Epub 2018 Aug 9.
10
Pediatric liver transplantation for hepatoblastoma: a single center experience.小儿肝母细胞瘤的肝移植:单中心经验
Transplant Proc. 2012 Mar;44(2):523-5. doi: 10.1016/j.transproceed.2012.01.069.

引用本文的文献

1
Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation.肝母细胞瘤传统临床治疗的进展与治疗创新。
World J Pediatr Surg. 2021 Jun 8;4(3):e000220. doi: 10.1136/wjps-2020-000220. eCollection 2021.
2
Usefulness of central radiologic review in clinical trials of children with hepatoblastoma.中央放射学审查在儿童肝母细胞瘤临床试验中的实用性。
Pediatr Radiol. 2023 Mar;53(3):367-377. doi: 10.1007/s00247-022-05530-4. Epub 2022 Oct 18.
3
Changes in the indications for living donor liver transplantation: single-institution experience of 3,145 cases over 10 years.
活体肝移植适应证的变化:一家机构10年3145例病例的经验
Korean J Transplant. 2020 Mar 31;34(1):47-54. doi: 10.4285/kjt.2020.34.1.47.
4
Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.显微镜下切缘阳性的肝母细胞瘤患儿肝切除术后生存的影响:一项回顾性队列研究。
Int J Clin Oncol. 2020 Apr;25(4):765-773. doi: 10.1007/s10147-019-01573-0. Epub 2019 Nov 7.
5
Navigation surgery using indocyanine green fluorescent imaging for hepatoblastoma patients.使用吲哚菁绿荧光成像技术对肝母细胞瘤患者进行导航手术。
Pediatr Surg Int. 2019 May;35(5):551-557. doi: 10.1007/s00383-019-04458-5. Epub 2019 Feb 16.
6
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.用于肝胆恶性肿瘤的肝移植:“移植肿瘤学”的新时代已经开启。
Surg Today. 2017 Apr;47(4):403-415. doi: 10.1007/s00595-016-1337-1. Epub 2016 Apr 29.
7
Indications, limitations and maneuvers to enable extended hepatectomy: current trends.扩大肝切除术的适应证、局限性及操作方法:当前趋势
World J Gastroenterol. 2014 Jun 28;20(24):7887-93. doi: 10.3748/wjg.v20.i24.7887.
8
Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.恶性肿瘤器官置换方法的现状以及器官生物工程与再生医学的序曲。
Organogenesis. 2014 Apr-Jun;10(2):241-9. doi: 10.4161/org.29245. Epub 2014 May 16.
9
Morbidity and mortality associated with liver resections for primary malignancies in children.儿童原发性恶性肿瘤肝切除术后的发病率和死亡率。
Pediatr Surg Int. 2014 May;30(5):493-7. doi: 10.1007/s00383-014-3492-z. Epub 2014 Mar 20.
10
Current therapeutic strategies for childhood hepatic tumors: surgical and interventional treatments for hepatoblastoma.儿童肝脏肿瘤的当前治疗策略:肝母细胞瘤的手术和介入治疗。
Int J Clin Oncol. 2013 Dec;18(6):962-8. doi: 10.1007/s10147-013-0625-7. Epub 2013 Oct 17.